These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3047383)
21. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding. Llewellyn JG; Pritchard MH J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979 [TBL] [Abstract][Full Text] [Related]
22. [Cytoprotective effect of rosaprostol during treatment with non-steroidal anti-inflammatory agents in arthrorheumatic pathologies]. Cataldo MG; Sallì L; Scalici G; D'Aiuto A; Bongiorno A; Salerno L Minerva Dietol Gastroenterol; 1989; 35(3):191-4. PubMed ID: 2601868 [TBL] [Abstract][Full Text] [Related]
23. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugs. Pincus T; Marcum SB; Callahan LF; Adams RF; Barber J; Barth WF; Gordon GV; Huston JW; Polk JR; Whelton JC J Rheumatol; 1992 Dec; 19(12):1874-84. PubMed ID: 1294734 [TBL] [Abstract][Full Text] [Related]
24. Prophylaxis of nonsteroidal antiinflammatory drug gastropathy: a clinical opinion. Roth SH; Fries JF; Abadi IA; Hubscher O; Mintz G; Samara AM J Rheumatol; 1991 Jul; 18(7):956-8. PubMed ID: 1920327 [No Abstract] [Full Text] [Related]
25. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. Kremer JM; Hamilton RA J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147 [TBL] [Abstract][Full Text] [Related]
26. Risk factors and current NSAID use. Simon LS J Rheumatol; 1999 Jul; 26(7):1429-31. PubMed ID: 10405924 [No Abstract] [Full Text] [Related]
27. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis. Lapane KL; Spooner JJ; Pettitt D Am J Manag Care; 2001 Apr; 7(4):402-8. PubMed ID: 11310194 [TBL] [Abstract][Full Text] [Related]
28. [Efficacy of sucralfate in the prevention of stomach diseases induced by non-steroidal anti-inflammatory drugs]. Fioravanti A; Giordano N; Biasi G; Vaccai D; Cataldi V; Marcolongo R Clin Ter; 1989 Sep; 130(6):333-6. PubMed ID: 2530034 [TBL] [Abstract][Full Text] [Related]
29. From peptic ulcer disease to NSAID gastropathy. An evolving nosology. Roth SH Drugs Aging; 1995 May; 6(5):358-67. PubMed ID: 7647425 [TBL] [Abstract][Full Text] [Related]
30. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN; Callaghan R; Allen ME; Rowe IF Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [TBL] [Abstract][Full Text] [Related]
31. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558 [TBL] [Abstract][Full Text] [Related]
32. Prophylaxis of NSAID gastropathy. Roth SH J Rheumatol; 1992 Apr; 19(4):662. PubMed ID: 1593593 [No Abstract] [Full Text] [Related]
39. Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study. Pazzi P; Scagliarini R; Sighinolfi D; Govoni M; La Corte R; Gullini S Am J Gastroenterol; 1998 Sep; 93(9):1420-4. PubMed ID: 9732918 [TBL] [Abstract][Full Text] [Related]
40. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia]. Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]